Understanding State Sovereign Immunity

The doctrine of state sovereign immunity traces its origins to the Eleventh Amendment of the U.S. Constitution, which was ratified in 1795 to overturn a Supreme Court decision that allowed private citizens to sue states in federal court. The amendment provides that “the Judicial power of the United States shall not be construed to extend to any suit in law or equity, commenced or prosecuted against one of the United States by Citizens of another State, or by Citizens or Subjects of any Foreign State.” Over time, courts have interpreted this provision to mean that states generally cannot be sued in federal court without their consent, even by their own citizens. This constitutional shield is rooted in the principle of state sovereignty and the idea that a state’s dignity and fiscal stability would be undermined if it were exposed to lawsuits in federal forums.

The doctrine, however, is not absolute. Congress may abrogate state sovereign immunity under Section 5 of the Fourteenth Amendment when it seeks to enforce constitutional rights, and states may voluntarily waive their immunity by accepting federal funds or by statute. Additionally, the Ex parte Young exception allows lawsuits against state officials in their official capacity for prospective injunctive relief to stop ongoing violations of federal law. Despite these exceptions, sovereign immunity remains a formidable barrier in many health and safety contexts.

Impact on Health Regulations

State sovereign immunity creates a complex landscape for the enforcement of health and safety regulations. When a state or its agencies are alleged to have violated federal or state health statutes—such as those governing air quality, drinking water standards, infectious disease control, or workplace safety—the state often invokes immunity to block private lawsuits or class actions. This leaves affected communities, patients, workers, and advocacy groups with limited recourse. The following sections examine specific areas where sovereign immunity intersects with public health.

Environmental Health and Pollution Control

Environmental health regulations, including the Clean Air Act, Clean Water Act, and Resource Conservation and Recovery Act, impose obligations on states to implement and enforce pollution standards. However, when state agencies fail to meet federal benchmarks or permit illegal discharges, private citizens seeking enforcement under citizen suit provisions may find themselves blocked by sovereign immunity. For example, in Department of Energy v. Ohio (1992), the Supreme Court held that the Clean Water Act did not clearly abrogate state sovereign immunity, limiting the ability of private plaintiffs to sue states for civil penalties. Similarly, states have argued immunity when communities challenged permits for hazardous waste facilities or sought cleanup of contaminated sites. The practical effect is that federal enforcement—often slowed by resource constraints—becomes the primary tool, and states themselves may use immunity as a shield against accountability for environmental health harms.

Public Health Emergencies and Infectious Disease Control

During public health crises—such as the COVID-19 pandemic, hepatitis A outbreaks, or foodborne illness clusters—state health departments play a central role in surveillance, testing, quarantine orders, and vaccination campaigns. Sovereign immunity can complicate litigation when individuals or businesses claim that state actions (or inactions) violated their rights or caused harm. For instance, nursing home residents and families who sued state health departments for failing to enforce infection control standards during the pandemic often faced motions to dismiss based on sovereign immunity. Courts have reached varied outcomes: some found that state officials were entitled to immunity under the Eleventh Amendment for decisions made during emergencies, while others allowed suits to proceed under the Ex parte Young exception when plaintiffs sought injunctive relief to require compliance with federal regulations.

The tension is clear: states need flexibility to respond rapidly and may be reluctant to face litigation that could drain budgets or second‑guess emergency decisions. Yet, without the possibility of accountability, there is a risk that public health measures will be ineffective or inequitably applied. The CDC’s Public Health Law Program has noted that sovereign immunity can create disincentives for state health agencies to adopt robust enforcement mechanisms.

Workplace Safety and Occupational Health

Occupational Safety and Health Act (OSH Act) enforcement is primarily handled by the federal Occupational Safety and Health Administration (OSHA) or state‑run plans approved by OSHA. In state‑plan states, workers or unions who sue the state for failure to inspect or for negligent enforcement of safety standards may be barred by sovereign immunity. The Supreme Court’s decision in Pennsylvania v. Union Gas Co. (1989) initially allowed suits under the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA) against states, but later cases have narrowed abrogation. Today, most courts hold that the OSH Act does not clearly abrogate state sovereign immunity. Consequently, workers exposed to hazardous conditions may find that the only path to relief is through a federal administrative claim under the FTCA, which imposes strict notice requirements and caps damages.

Food Safety and Consumer Health

State agriculture and health departments oversee inspections of food processing plants, restaurants, and retail establishments. When a state inspection fails to identify a pathogen—such as Salmonella or E. coli—and a consumer falls ill, sovereign immunity often prevents a direct tort lawsuit against the state agency. Instead, victims must rely on the state’s tort claims act or seek compensation from the food producer. This limitation can reduce the incentive for state regulators to invest in advanced testing or more frequent inspections. In states with caps on damages under their tort claims acts, the economic impact on public health is further muted, potentially leading to under‑enforcement of food safety regulations.

While sovereign immunity is robust, courts have carved out several mechanisms that can overcome it in health and safety cases. Understanding these exceptions is critical for policymakers and advocates.

Federal Tort Claims Act (FTCA) and State Analogues

The FTCA permits lawsuits against the United States for certain torts committed by federal employees, but it does not waive immunity for states. However, every state has enacted its own state tort claims act that partially waives immunity for negligence claims, often subject to caps on damages and shortened statutes of limitations. In some states, these waivers are narrow: they may exclude discretionary functions (e.g., policy decisions about resource allocation during an outbreak) or apply only to incidents involving state‑owned property. For health‑related claims, the discretionary function exception has been a frequent battleground. Courts generally protect state decisions that involve balancing economic, social, or health priorities, meaning that many public health actions are insulated from liability.

Ex parte Young and Official‑Capacity Suits for Injunctive Relief

The landmark case Ex parte Young (1908) established that a suit against a state official seeking prospective injunctive relief to stop an ongoing violation of federal law is not barred by sovereign immunity. This exception is frequently invoked in health regulation cases where the plaintiff asks a court to order a state official to comply with environmental permits, to implement a required inspection program, or to disseminate public health warnings. For example, environmental groups have used Ex parte Young to compel state environmental agencies to take action under the Clean Water Act, and disability advocates have used it to enforce the Americans with Disabilities Act in state health facilities. However, the exception does not allow for retroactive damages, so it is of limited use for compensating past harms.

Congressional Abrogation Under Section 5 of the Fourteenth Amendment

Congress may abrogate state sovereign immunity when it legislates under Section 5 of the Fourteenth Amendment—that is, to enforce constitutional rights such as equal protection and due process. The Supreme Court has held that abrogation must be “unmistakably clear in the language of the statute.” Several federal health statutes, including portions of the Americans with Disabilities Act and the Rehabilitation Act, have been upheld as valid abrogation. In Tennessee v. Lane (2004), the Court found that Title II of the ADA validly abrogated immunity for cases involving access to state court services, which has implications for public health programs that discriminate against people with disabilities. Conversely, the Court has rejected abrogation under the Age Discrimination in Employment Act and some environmental statutes, meaning that the scope of this exception is limited and subject to ongoing litigation.

Waiver Through Participation in Federal Programs

When states accept federal funds under programs like Medicaid, Title X family planning, or public health preparedness grants, they often must agree to waive sovereign immunity for certain claims arising out of the operation of those programs. For instance, the Medicaid statute conditions participation on a state’s agreement to be sued in federal court by beneficiaries for violations of federal law. Courts have recognized that this constitutes a clear waiver. However, the waiver is typically narrow—it applies only to claims under the specific program’s provisions, not to general tort claims related to health services. States may also waive immunity by initiating litigation or by enacting statutes that consent to suit in specific health‑related contexts, such as medical malpractice in public hospitals.

Abrogation Under Federal Civil Rights Statutes (Section 1983)

Section 1983 of the Civil Rights Act allows individuals to sue state officials for violations of federal constitutional or statutory rights. While Section 1983 itself does not abrogate sovereign immunity (states are not “persons” under the statute), state officials in their individual capacities can be sued for damages. This distinction is crucial: a plaintiff cannot sue the state health department itself under Section 1983, but they can sue the health commissioner in their personal capacity for violating constitutional rights, such as the right to due process or equal protection. The threat of personal liability can incentivize individual officials to comply with health regulations, but it also raises concerns about chilling public health decision‑making. Qualified immunity often protects officials from damages unless they violated clearly established law, which can be difficult to prove in novel health‑policy contexts.

Implications for Policy and Enforcement

The interaction between sovereign immunity and health regulation presents a structural challenge for public health advocates, policymakers, and enforcement agencies. On one hand, sovereign immunity protects states from excessive litigation that could divert resources from critical health services and allows states to take decisive action during emergencies without paralyzing uncertainty. On the other hand, when immunity is too broad, it can create accountability gaps that undermine health safety standards.

Legislative Reforms

Some reformers have called for state‑level legislation to narrow sovereign immunity in health‑related contexts. For example, states could pass laws explicitly waiving immunity for claims related to environmental contamination that causes personal injury, or for negligence in the operation of public health laboratories. Others advocate for clearer federal abrogation language in statutes such as the Clean Air Act or the Food, Drug, and Cosmetic Act. The National Conference of State Legislatures has published model legislation addressing sovereign immunity in public health, though adoption has been uneven. Another approach is to condition federal health grants on broader waivers, similar to the Medicaid model, as a way to encourage states to accept accountability in exchange for funding.

The Role of the Federal Government

When states are immune, much of the enforcement burden falls on federal agencies like the Environmental Protection Agency (EPA), the Department of Health and Human Services (HHS), and OSHA. These agencies can bring enforcement actions directly against states for non‑compliance with federal laws (e.g., the EPA can sue a state for failing to implement a Clean Air Act state implementation plan). However, federal resources are finite, and agencies may be reluctant to sue states with which they must maintain cooperative relationships. This reality means that gaps in enforcement persist, especially for issues that are not a federal priority. Some commentators have suggested creating an independent federal commission with standing to sue states for public health violations, similar to the special counsel for vaccine‑injury claims, but such proposals face political obstacles.

Policy Recommendations for Public Health Officials

State and local health officials should be aware of the limits sovereign immunity places on their liability and the ways in which they can nevertheless be held accountable through Ex parte Young injunctions or Section 1983 individual‑capacity suits. Officials can reduce litigation risk by: (a) ensuring that policies are grounded in scientific evidence and clearly authorized by statute; (b) documenting decision‑making processes, especially during emergencies; and (c) maintaining transparent communication with affected communities. Additionally, states should consider establishing voluntary dispute‑resolution processes for health and safety complaints, which can offer a path to corrective action without resorting to litigation. The Association of State and Territorial Health Officials (ASTHO) provides guidance on legal preparedness that addresses sovereign immunity considerations.

The Balancing Act: Sovereignty vs. Public Health

The tension between state sovereignty and the need for enforceable health and safety regulations is unlikely to be resolved entirely. The dual‑sovereignty structure of U.S. federalism means that health regulation will always involve a bargain between state autonomy and federal oversight. Sovereign immunity is a central component of that bargain, but it is not static. Court decisions, legislative amendments, and changes in public health practice continually reshape its boundaries.

For instance, the COVID-19 pandemic spurred a wave of litigation over state quarantine orders, vaccine mandates, and nursing home policies. Some lawsuits succeeded under Ex parte Young by challenging the constitutionality of orders that allegedly violated due process or equal protection, while others were dismissed because the state agency itself remained immune. These cases have prompted renewed scholarly and policy debate about whether sovereign immunity should be curtailed in public health emergencies—especially when state actions have disproportionate impacts on vulnerable populations.

Conclusion

State sovereign immunity remains a formidable legal doctrine that significantly shapes the enforcement landscape for health and safety regulations. While it serves important purposes—protecting state treasuries, preserving federalism, and allowing flexible response to crises—it can also obstruct efforts to hold states accountable for failing to meet health standards. The interplay of exceptions such as Ex parte Young, congressional abrogation, and waiver through federal funding provides partial remedies, but these alternatives are often costly, piecemeal, and inaccessible to many affected individuals and communities.

Policymakers at both the state and federal levels must grapple with the question of how to design legal regimes that respect legitimate state prerogatives while ensuring that public health is not sacrificed on the altar of immunity. As the body of case law continues to evolve—especially in the aftermath of the pandemic and in the face of climate‑driven environmental health risks—so too must the strategies of advocates, health officials, and legislators. An informed understanding of sovereign immunity is essential for anyone working to strengthen health and safety protections in a federal system.